Table of Contents Table of Contents
Previous Page  138 / 398 Next Page
Information
Show Menu
Previous Page 138 / 398 Next Page
Page Background

133

constitute 1–13% of orbital tumours and metastatic breast can-

cer is the most common type to metastasise to the orbit, followed

by metastatic prostate carcinoma, melanoma, and lung cancer.

However, to the best of the author’s knowledge the nature of

the pathology and the absence of a primary, make this case truly

unique.

http://dx.doi.org/10.1016/j.ijom.2017.02.461

Do preoperative anaemias predict outcomes in surgical head

and neck oncology?

Z. Sadiq

∗

, E. Burdett, N. Kaur, N. Kalavrezos

University College London Hospital, United Kingdom

Background:

Anaemia is present in 5–78% of patients requiring

surgical intervention. Preoperative anaemia is independently asso-

ciated with adverse outcomes after general and cardiac surgery.

It is an independent risk factor for adverse perioperative events

and is associated with an increased transfusion requirement in

patients undergoing oncology related gynaecological procedures.

The incidence and impact of preoperative anaemia in major head

and neck oncology surgery is not clearly defined, neither its util-

ity as a surrogate marker for transfusion requirements. Recently

published guidelines advocate correction of anaemia pre-elective

surgery to improve outcomes.

Objectives:

We aimed to explore the incidence and impact of

preoperative anaemia in patients with head and neck cancer under-

going major resection and reconstruction.

Methods:

We collected retrospective data over a 2-year period

from the hospital dataset including patient demographics, preop-

erative haemoglobin, transfusion incidence, transfusion quantity,

transfusion product type, ASA Grade, surgical procedures, the

incidence of microvascular flap complication, length of stay and

a record of neoadjuvant chemotherapy.

Findings and Conclusions:

We will present the transfusion

profile of head and neck cancer patients at our cancer centre,

identifying the relationship between preoperative anaemia and

the requirement for replacement with blood products. The authors

will present the association between depleted levels and impact on

patient outcomes as specified by the aforementioned measures.

http://dx.doi.org/10.1016/j.ijom.2017.02.462

Can we rely on fine-needle aspiration result in the

management of patient with Warthin’s tumour?

U. Selbong

∗

, I. Pereira, D. Laugharne, K. Jones

Royal Derby Hospital, Derby, United Kingdom

Background:

Warthin’s tumour usually managed nonsurgically

with periodic clinical and radiological evaluation. Fine-needle

aspiration (FNA) and cytology routinely performed in addition

to magnetic resonance scan when assessing these tumours. We

would like to determine if we can safely manage nonsurgically

patient with FNA suggestive of Warthin’s tumour.

Methods:

We retrospectively audited all consecutive FNAs done

for patients presenting with parotid tumour to maxillofacial clinic

Royal Derby Hospital for the period of April 2010 to March 2015

who later underwent definitive surgical procedure. FNA results,

type of surgical procedure and final histology results were ana-

lysed.

Results:

104 patients who had FNA performed for parotid mass

were identified for this audit. 27 patients who had FNA reported

as Warthin’s tumour underwent superficial parotidectomy. 24

patients had final histology confirming the diagnosis of Warthin’s

tumour. The sensitivity of FNA in detecting Warthin’s tumour was

100% as all patients who had confirmed diagnosis also had simi-

lar FNA result (

n

= 24). The specificity of FNA in confirming the

diagnosis was 96.6%. 3 patients who had initial FNA suggestive of

Warthin’s tumour had final histology reported as mucoepidermoid

carcinoma, acinic cell carcinoma and Schwannoma respectively.

The positive predictive value for FNA in diagnosing Warthin’s

tumour was 88.9% and negative predictive value was 100%.

Discussion:

FNA is a sensitive tool in assessingWarthin’s tumour.

However this audit clearly showed the limitation of FNA in detect-

ing malignant tumours. 11% of patients (

n

= 3) had malignancy

undetected and could be subjected to nonsurgical observation with

devastating outcomes.

http://dx.doi.org/10.1016/j.ijom.2017.02.463

Personalised treatment of paediatric mucoepidermoid

carcinoma of the palate

L. Shao

∗

, W.Q. Li, D. Li, M. Huang, W.M. Chen

Department of Oral and Maxillofacial Surgery, Tongji Hospital,

Huazhong University of Science and Technology, Wuhan, Hubei,

China

Background:

In children, malignant minor palate salivary gland

neoplasms are rare. Furthermore, a large, highly vascular tumour

of the palate, with exception of true vascular lesion, has seldom

been noticed. This report is to alert clinicians the phenomenon of

palate mucoepidermoid carcinoma (MEC) in a male teenager and

aims to stress the personalised treatment effect.

Methods:

A tender vascular multinodular lump centralised in the

left hard palate was shown in the presentation. The vascular nidus

was verified by fine-needle aspiration (FNA), the subsequent dig-

ital subtraction angiography (DSA) and additional embolisation.

After MEC was confirmed in the initial resection biopsy, the sec-

ond margin ablation and brachytherapy was performed to acquire

safety margin. The ablative palate defect was reconstructed, when

recurrence andmetastasis was excluded after the one-year compre-

hensive examination. The succeeding follow-up was uneventful,

until the boy of eighteen had dental examinations. Computed

tomography scan found four wisdom un-erupted teeth, maxillary

mesodens and the obvious left maxilla hypoplasia. The mesodens

and all the wisdom teeth were surgically extracted afterwards, the

wounds was well healed.

Results:

In the more than five-years follow-up, the teenager was

without recurrence and metastasis. In addition, both contour and

function of the palate were excellent.

Conclusions:

Highly vascular MEC could be occurred in the

palate of teenage. Personalised therapy, including the compre-

hensive vascular intervention, tumour ablation, brachytherapy and

the reconstruction, remains a potentially successful strategy in the

management of the large, highly vascular paediatric palate mass,

unless malignant could be excluded.

http://dx.doi.org/10.1016/j.ijom.2017.02.464